Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,060 | 16,761 | 5,666 | 13,429 | 16,043 |
| Marketable Securities | 40,132 | 31,514 | 30,470 | 23,467 | 31,622 |
| Receivables | 812 | 642 | 669 | 790 | 827 |
| Other current assets | 3,807 | 10,423 | 27,406 | 32,106 | 27,938 |
| TOTAL | $51,811 | $59,340 | $64,211 | $69,792 | $76,430 |
| Non-Current Assets | |||||
| PPE Net | 176 | 176 | 157 | 161 | 171 |
| Other Non-Current Assets | 394 | 437 | 481 | 486 | 538 |
| TOTAL | $570 | $613 | $638 | $647 | $709 |
| Total Assets | $52,381 | $59,953 | $64,849 | $70,439 | $77,139 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,012 | 6,050 | 4,714 | 6,033 | 6,934 |
| TOTAL | $8,012 | $6,050 | $4,714 | $6,033 | $6,934 |
| Non-Current Liabilities | |||||
| TOTAL | $216 | $247 | $251 | $302 | $352 |
| Total Liabilities | $8,228 | $6,297 | $4,965 | $6,335 | $7,286 |
| Shareholders' Equity | |||||
| Common Shares | 58 | 58 | 58 | 58 | 58 |
| Retained earnings | -135,707 | -125,430 | -118,525 | -112,999 | -106,936 |
| Other shareholders' equity | 272 | 90 | 498 | -227 | 35 |
| TOTAL | $44,153 | $53,656 | $59,884 | $64,104 | $69,853 |
| Total Liabilities And Equity | $52,381 | $59,953 | $64,849 | $70,439 | $77,139 |